Radiopharmaceuticals.

Ended Awarded

Contract number
HT009023FG0110045
Awardee
Awarding agency
Obligated
$20,976

Award facts

Contract value 100% obligated
$20,976.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sterling, VA, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $20,976 firm fixed price call against the Defense Health Agency's Basic Pricing Agreement for radiopharmaceuticals. The contract has no set-aside designation and requires delivery of the requested pharmaceutical products to locations in Sterling, Virginia through September 2023. As the DHA works to ensure service members and their families have access to quality healthcare, this contract will support their efforts to provide radiopharmaceuticals in the National Capital Region through next fiscal year.

Quick answers

Who was awarded contract HT009023FG0110045?

HT009023FG0110045 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on January 12, 2023.

How much is contract HT009023FG0110045 worth?

The government has obligated $20,976 on HT009023FG0110045.

Is contract HT009023FG0110045 an order under another contract?

Yes. HT009023FG0110045 is a BPA call under HT001421A0014, a blanket purchase agreement.

Was contract HT009023FG0110045 competed?

The extent of competition for HT009023FG0110045 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login